Treatment results and prognostic factors in primary thyroid lymphoma patients: a Rare Cancer Network study

Onal C., Li Y. X., Miller R. C., Poortmans P., Constantinou N., Weber D. C., ...Daha Fazla

ANNALS OF ONCOLOGY, cilt.22, sa.1, ss.156-164, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 1
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1093/annonc/mdq310
  • Dergi Adı: ANNALS OF ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.156-164
  • Anahtar Kelimeler: chemotherapy, combined modality treatment, non-Hodgkin's lymphoma, prognostic factors, radiotherapy, thyroid lymphoma, B-CELL LYMPHOMA, NON-HODGKINS-LYMPHOMA, MALIGNANT-LYMPHOMA, LOCALIZED INTERMEDIATE, ONCOLOGY-GROUP, GLAND, RADIOTHERAPY, CHEMOTHERAPY, THERAPY, CHOP
  • Marmara Üniversitesi Adresli: Evet

Özet

Background: This study analyzed prognostic factors and treatment outcomes of primary thyroid lymphoma.